San Diego, CA · Founded 2025 · Privately Held (backing)
Developer of innovative therapeutics designed to address the significant unmet medical needs of people living with gout. Crystalys Therapeutics is based in San Diego, CA and was founded in 2025. Its last reported valuation was $263 million in Sep 2025. It has raised $205 million.
Last reported valuation
$263.0M
Oct 2026
Priced at
—
Total raised
$205.0M
Last round
—
Cap table — not yet on record
Crystalys Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Crystalys Therapeutics with a free account
·The complete investor list: 15 names
·Watch Crystalys Therapeutics: the Monday email on marks, rounds and moves
